Results 231 to 240 of about 211,965 (305)

Twelve‐Month Real‐World Outcomes of Faricimab for Treatment‐Naive Neovascular AMD in Australia

open access: yesClinical &Experimental Ophthalmology, EarlyView.
ABSTRACT Background To provide insights into the effectiveness and safety of faricimab for treatment‐naïve eyes with neovascular age‐related macular degeneration (nAMD). Methods A retrospective cohort study using a prospectively‐designed registry. Treatment‐naïve eyes with nAMD in Australia starting treatment with faricimab between Jan 2023–Sep 2024 ...
Mark Gillies   +8 more
wiley   +1 more source

Potential Medicare Part D Savings on Ophthalmic Generic Drugs.

open access: yesJAMA Ophthalmol
Collet DA, Urban MB, Amin A.
europepmc   +1 more source

Parent's Perceptions of the Family Impacts of COVID‐19 Lockdowns on Themselves and Siblings of Children With Developmental Disabilities: ‘No Time to Breathe’

open access: yesChild &Family Social Work, EarlyView.
ABSTRACT Family members may be impacted by complex care requirements around childhood disability, although little research provides guidance on the changing needs of families under unexpected circumstances. This study investigated parents' experiences and reports of the impact of COVID‐19 lockdowns in Australia on family members in families raising a ...
Helen Bourke‐Taylor   +6 more
wiley   +1 more source

Health insurance and labor supply: Evidence from same‐sex couples

open access: yesContemporary Economic Policy, EarlyView.
Abstract This paper examines labor supply effects of policies allowing public sector workers to include same‐sex partners in employer‐sponsored insurance plans. Unlike broader partnership recognition rights, these policies focus narrowly on insurance access.
Elisabeth Wurm
wiley   +1 more source

Home - About - Disclaimer - Privacy